Back to GetFilings.com




 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

FORM 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the quarterly period ended April 30, 2005

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

For the transition period from                      to                     

 

Commission file number 000-29665

 

EXCELSIOR VENTURE PARTNERS III, LLC

(Exact Name of Registrant as Specified in Its Charter)

 

DELAWARE   13-4102528
(State or Other Jurisdiction of Incorporation or Organization)   (I.R.S. Employer Identification No.)
225 High Ridge Road, Stamford, CT   06905
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code (203) 352-4400

 

114 West 47th Street, New York, NY 10036-1532

Former Name, Former Address and Former Fiscal Year, if Changed Since last Report.

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined by Rule 12b-2 of the Act).    Yes  ¨    No  x

 



EXCELSIOR VENTURE PARTNERS III, LLC

 

This Quarterly Report on Form 10-Q contains historical information and forward-looking statements. Statements looking forward in time are included in this Form 10-Q pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. They involve known and unknown risks and uncertainties that may cause Excelsior Venture Partners III, LLC’s (the “Company’s”) actual results to differ from future performance suggested herein.

 

    

INDEX


   PAGE NO.

PART I.

   FINANCIAL INFORMATION     

Item 1.

   Financial Statements    1
     Portfolios of Investments as of April 30, 2005 and October 31, 2004    2
     Statements of Assets and Liabilities at April 30, 2005 and October 31, 2004    9
     Statements of Operations for the six-month periods ended April 30, 2005 and April 30, 2004    10
     Statements of Operations for the three-month periods ended April 30, 2005 and April 30, 2004    11
     Statements of Changes in Net Assets for the six-month periods ended April 30, 2005 and April 30, 2004    12
     Statements of Cash Flows for the six-month periods ended April 30, 2005 and April 30, 2004    13
     Financial Highlights for the six-month periods ended April 30, 2005 and April 30, 2004    14
     Notes to Financial Statements    15

Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    21

Item 3.

   Quantitative and Qualitative Disclosures about Market Risk    23

Item 4.

   Controls and Procedures    24

PART II.

   OTHER INFORMATION     

Item 1.

   Legal Proceedings    24

Item 2.

   Changes in Securities and Use of Proceeds    24

Item 3.

   Defaults Upon Senior Securities    24

Item 4.

   Submission of Matters to a Vote of Security Holders    24

Item 5.

   Other Information    24

Item 6.

   Exhibits and Reports on Form 8-K    24

 


PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Excelsior Venture Partners III, LLC

Portfolio of Investments (Unaudited)

 

     April 30, 2005

 
     Value

   Percent of Net
Assets


 

PORTFOLIO STRUCTURE

             

SHORT-TERM INVESTMENTS:

             

MONEY MARKET INSTRUMENTS

   $ 29,989,072    28.62 %

INVESTMENT COMPANIES

     1,808,874    1.73 %

PRIVATE COMPANIES

     58,850,495    56.17 %

PUBLIC COMPANIES

     6,196,003    5.91 %

PRIVATE INVESTMENT FUNDS

     7,244,592    6.91 %
    

  

TOTAL INVESTMENTS

     104,089,036    99.34 %

OTHER ASSETS & LIABILITIES (NET)

     689,601    0.66 %
    

  

NET ASSETS

   $ 104,778,637    100.00 %
    

  

 

Excelsior Venture Partners III, LLC

Portfolio of Investments

 

     October 31, 2004

 
     Value

   Percent of Net
Assets


 

PORTFOLIO STRUCTURE

             

SHORT-TERM INVESTMENTS:

             

MONEY MARKET INSTRUMENTS

   $ 44,139,985    38.03 %

INVESTMENT COMPANIES

     1,386,211    1.19 %

PRIVATE COMPANIES

     60,065,508    51.75 %

PUBLIC COMPANIES

     4,682,927    4.03 %

PRIVATE INVESTMENT FUNDS

     5,456,505    4.70 %
    

  

TOTAL INVESTMENTS

     115,731,136    99.70 %

OTHER ASSETS & LIABILITIES (NET)

     348,297    0.30 %
    

  

NET ASSETS

   $ 116,079,433    100.00 %
    

  

 

Notes to Financial Statements are an integral part of these Financial Statements.

 

1


Excelsior Venture Partners III, LLC

Portfolio of Investments April 30, 2005 (Unaudited)

 

Principal
Amount/Shares


       

Acquisition

Date ##


  

Value

(Note 1)


  TOTAL MONEY MARKET INSTRUMENTS — 28.62%            
$ 5,000,000    Royal Bank of Scotland Commercial Paper, 2.75%, 5/2/05 (Cost $4,999,236)         $ 4,999,236
  10,000,000    Federal Farm Credit Bureau Discount Note, 2.65%, 5/3/05 (Cost $9,997,634)           9,997,634
  5,000,000    Du Pont Commercial Paper, 2.75%, 5/5/05 (Cost $4,998,091)           4,998,091
  5,000,000    Morgan Stanley Commercial Paper, 2.80%, 5/5/05 (Cost $4,998,056)           4,998,056
  5,000,000    UBS Financial Commercial Paper, 2.84%, 5/10/05 (Cost $4,996,055)           4,996,055
                

       TOTAL MONEY MARKET INSTRUMENTS (COST $29,989,072)           29,989,072
                

  PUBLIC COMPANIES — 5.91%            
  Common Stocks — 5.91%            
  Life Sciences — 5.91%            
  485,961    Adeza Biomedical Corp.    09/01      6,196,003
                

       (Nasdaq: ADZA)            
       TOTAL COMMON STOCKS (Cost $3,000,000)           6,196,003
                

  PRIVATE COMPANIES **, #, @ — 56.17%            
  Common Stocks — 0.00%            
  Capital Equipment — 0.00%            
  157,396    MIDAS Vision Systems, Inc.    03/03      —  
                

  Life Sciences — 0.00%            
  46,860    Genoptix, Inc.    07/03      —  
                

       TOTAL COMMON STOCKS (Cost $4,000,000)           —  
                

  Preferred Stocks — 50.42%            
  Capital Equipment — 0.00%            
  933,593    MIDAS Vision Systems, Inc., Series A-1    03/03      —  
                

  Enterprise Software — 11.36%            
  19,995,000    ***Datanautics, Inc. Series A Preferred    01/04      4,000,000
  8,532,883    LogicLibrary, Inc., Series A    01/02, 08/03,
05/04, 12/04, 2/05
     3,901,408
  20,000,000    ***Pilot Software Inc., Series A    05/02 & 04/03      4,000,000
                

                   11,901,408
                

  Information Services — 0.00%            
  4,425    Cenquest, Inc., Series 2    7/01      —  
                

  Life Sciences — 4.20%            
  1,999,999    Archemix Corporation, Inc., Series A    08/02, 01/03, 11/03      1,999,999
  466,666    Archemix Corporation, Inc., Series B    03/04 & 09/04      466,666
  942,481    Genoptix, Inc., Series B-1    12/01      501,400
  1,403,696    Genoptix, Inc., Series B-2    07/03, 09/03, 12/03      877,450
  620,580    Genoptix, Inc., Series C    08/04 & 01/05      554,178
                

                   4,399,693
                

  Medical Technology — 6.13%            
  4,166,667    Tensys Medical, Inc., Series C    03/02      5,000,000
  1,187,500    Tensys Medical, Inc., Series D    05/04      1,425,000
                

                   6,425,000
                

  Optical — 13.08%            
  4,330,504    LightConnect, Inc., Series B    07/01      5,000,000
  12,292,441    LightConnect, Inc., Series C    12/02      992,000
  956,234    NanoOpto Corporation, Series A-1    10/01& 03/02      —  
  3,023,399    NanoOpto Corporation, Series B    09/03, 11/03,
01/04, 07/04
     1,655,119

 

2


Excelsior Venture Partners III, LLC

Portfolio of Investments April 30, 2005 (Unaudited) — (continued)

 

Principal
Amount/Shares/

Percent Owned


        

Acquisition

Date ##


  

Value

(Note 1)


  5,333,333     OpVista, Inc., Series B    07/01    $ —  
  12,671,059     OpVista, Inc., Series C    09/03      5,000,000
  102,040     OpVista, Inc., Series D    11/04      1,058,000
                 

                    13,705,119
  Semiconductor — 9.30%            
  7,000,000     Chips & Systems, Inc., Series A    03/04      —  
  2,211,898     Silverback Systems, Inc., Series B-1    02/02      450,052
  34,364,257     Silverback Systems, Inc., Series C    03/03, 09/03, 04/04      4,298,896
  3,096,551     Virtual Silicon Technology, Inc., Series C    12/01      5,000,000
                 

                    9.748,948
  Wireless — 6.35%            
  4,433,333     Ethertronics, Inc., Series B    06/01, 09/02, 07/03,
05/04
     6,650,001
                 

        TOTAL PREFERRED STOCKS (Cost $65,128,657)           52,830,169
                 

  Notes — 5.75%            
  Enterprise Software — 3.28%            
$ 1,433,178     ***Datanautics, Inc., Bridge Note    12/04, 01/05,
02/05, 03/05,
04/05
     1,433,178
  2,000,000     ***Pilot Software, Inc., Bridge Note    08/04, 09/04,
10/04, 11/04,
12/04
     2,000,000
                 

  Semiconductor—1.54 %            
  281,580     Virtual Silicon Technology, Inc., Bridge Note    10/04, 12/04,
02/05
     281,580
  1,441,133     Chips & Systems, Inc., Bridge Note    11/04, 01/05,
02/05
     —  
  1,333,400     Silverback Systems, Inc., Bridge Note    01/05, 04/05      1,333,400
                 

  Wireless— 0.24 %            
  250,000     Ethertronics, Inc., Bridge Note    01/05      250,000
                 

  Optical— 0.69 %            
  722,101     NanoOpto Corp., Bridge Note    12/04      722,101
                 

        TOTAL NOTES (Cost $7,461,392)           6,020,259
                 

  Warrants — 0.00%            
  Semiconductor — 0.00%            
  67     Silverback Systems, Inc., Warrant    04/05      67
                 

  Wireless — 0.00%            
  100,000     Ethertronics, Inc.    09/02      —  
  115,000     Ethertronics, Inc.    07/03      —  
  66,667     Ethertronics, Inc.    08/03      —  
                 

        TOTAL WARRANTS (Cost $67)           67
                 

        TOTAL — PRIVATE COMPANIES (Cost $76,590,116)           58,850,495
                 

  PRIVATE INVESTMENT FUNDS **, # — 6.91%            
  0.39 %   Advanced Technology Ventures VII, LP    08/01-04/05      845,375
  1.21 %   Burrill Life Sciences Capital Fund    12/02-12/04      1,014,860
  1.35 %   CHL Medical Partners II, LP    01/02-11/04      581,496
  4.94 %   CMEA Ventures Partners, LP    12/03-01/05      257,781
  0.36 %   Morgenthaler Partners VII, LP    07/01-01/05      1,341,285
  0.59 %   Prospect Venture Partners II, LP    06/01-03/05      1,393,042
  0.90 %   Sevin Rosen Fund VI, LP    10/04-01/05      282,093
  2.36 %   Tallwood II, LP    12/02-04/05      977,028

 

3


Excelsior Venture Partners III, LLC

Portfolio of Investments April 30, 2005 (Unaudited) — (continued)

 

Principal
Amount/Shares/

Percent Owned


        

Acquisition

Date ##


  

Value

(Note 1)


1.75 %   Valhalla Partners II, LP    10/03-03/05    $ 551,632
               

      TOTAL — PRIVATE INVESTMENT FUNDS (Cost $8,564,582)           7,244,592
               

INVESTMENT COMPANIES — 1.73%            
1,808,874     Dreyfus Government Cash Management Fund Institutional Shares (Cost $1,808,874)           1,808,874
               

TOTAL INVESTMENTS (Cost $119,952,644) — 99.34%           104,089,036
OTHER ASSETS & LIABILITIES (NET) — 0.66%           689,601